| Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell–cancer-associated fibroblast interactions during collective invasion AM Richardson, LS Havel, AE Koyen, JM Konen, J Shupe, WG Wiles IV, ... Clinical cancer research 24 (2), 420-432, 2018 | 214 | 2018 |
| Vimentin regulates lung cancer cell adhesion through a VAV2–Rac1 pathway to control focal adhesion kinase activity LS Havel, ER Kline, AM Salgueiro, AI Marcus Oncogene 34 (15), 1979-1990, 2015 | 169 | 2015 |
| FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells LT Taliaferro-Smith, E Oberlick, T Liu, T McGlothen, T Alcaide, R Tobin, ... Oncotarget 6 (7), 4757, 2015 | 127 | 2015 |
| A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies D Skokos, JC Waite, L Haber, A Crawford, A Hermann, E Ullman, R Slim, ... Science translational medicine 12 (525), eaaw7888, 2020 | 87 | 2020 |
| Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation LS Havel, CE Wang, B Wade, B Huang, S Li, XJ Li Human molecular genetics 20 (7), 1424-1437, 2011 | 73 | 2011 |
| Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival GJ Markowitz, LS Havel, MJP Crowley, Y Ban, SB Lee, JS Thalappillil, ... JCI insight 3 (13), 2018 | 61 | 2018 |
| Screening of human SNP database identifies recoding sites of A-to-I RNA editing WM Gommans, NE Tatalias, CP Sie, D Dupuis, N Vendetti, L Smith, ... Rna 14 (10), 2074-2085, 2008 | 60 | 2008 |
| Nuclear accumulation of polyglutamine disease proteins and neuropathology LS Havel, S Li, XJ Li Molecular brain 2, 1-7, 2009 | 55 | 2009 |
| Context-dependent dysregulation of transcription by mutant huntingtin J Cornett, L Smith, M Friedman, JY Shin, XJ Li, SH Li Journal of biological chemistry 281 (47), 36198-36204, 2006 | 27 | 2006 |
| Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake AB Weinglass, MG Köhler, EO Nketiah, J Liu, W Schmalhofer, A Thomas, ... Molecular Pharmacology 73 (4), 1072-1084, 2008 | 26 | 2008 |
| CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models J Wei, W Montalvo-Ortiz, L Yu, A Krasco, K Olson, S Rizvi, N Fiaschi, ... Science Translational Medicine 14 (670), eabn1082, 2022 | 20 | 2022 |
| WG t. Wiles, WD Martin, HE Grossniklaus, G. Sica, M. Gilbert-Ross and AI Marcus AM Richardson, LS Havel, AE Koyen, JM Konen, J Shupe Clin. Cancer Res 24, 420-432, 2018 | 18 | 2018 |
| FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget. 2015; 6: 4757–72 L Taliaferro-Smith, E Oberlick, T Liu, T McGlothen, T Alcaide, R Tobin, ... Oncogene 29, 251-262, 2010 | 7 | 2010 |
| Abstract C24: Beyond EMT: Vimentin function in lung cancer metastasis AM Salgueiro, M Gilbert-Ross, LS Havel, J Shupe, AE Koyen, ... Cancer Research 76 (15_Supplement), C24-C24, 2016 | | 2016 |
| EZH2 contributes to breast cancer metastasis S Yomtoubian, S Ryu, S Lee, L Havel, D Gao, V Mittal Cancer Research 76 (14_Supplement), 4447-4447, 2016 | | 2016 |
| Targeting immunosuppressive mechanisms in KRAS mutant lung cancer LS Havel, D Gao, JS Daniel, NK Altorki, V Mittal Journal of Thoracic Oncology 11 (2), S23-S24, 2016 | | 2016 |
| Abstract B172: Oncogene-mediated immune microenvironments in lung cancer provide a rationale for combination therapies LS Havel, D Gao, N Altorki, V Mittal Cancer Immunology Research 4 (1_Supplement), B172-B172, 2016 | | 2016 |
| More than a biomarker: Studying the role of vimentin in lung cancer metastasis AM Salgueiro, M Gilbert-Ross, LS Havel, J Shupe, AI Marcus Cancer Research 75 (15_Supplement), 2290-2290, 2015 | | 2015 |
| Abstract A52: Vimentin serves as a signaling scaffold at focal adhesion sites to regulate lung cancer cell adhesion L Havel, AI Marcus Cancer Research 73 (3_Supplement), A52-A52, 2013 | | 2013 |
| Vimentin regulates cell motility and cell adhesion through VAV2-Rac1 pathway that controls focal adhesion kinase activity LS Havel, A Marcus MOLECULAR BIOLOGY OF THE CELL 24, 2013 | | 2013 |
